These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Myeloperoxidase: a target for new drug development? Malle E; Furtmüller PG; Sattler W; Obinger C Br J Pharmacol; 2007 Nov; 152(6):838-54. PubMed ID: 17592500 [TBL] [Abstract][Full Text] [Related]
6. The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease. Davies MJ; Hawkins CL Antioxid Redox Signal; 2020 May; 32(13):957-981. PubMed ID: 31989833 [No Abstract] [Full Text] [Related]
7. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan. Rees MD; Whitelock JM; Malle E; Chuang CY; Iozzo RV; Nilasaroya A; Davies MJ Matrix Biol; 2010 Jan; 29(1):63-73. PubMed ID: 19788922 [TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Aratani Y Arch Biochem Biophys; 2018 Feb; 640():47-52. PubMed ID: 29336940 [TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase and Neurological Disorder: A Crosstalk. Pravalika K; Sarmah D; Kaur H; Wanve M; Saraf J; Kalia K; Borah A; Yavagal DR; Dave KR; Bhattacharya P ACS Chem Neurosci; 2018 Mar; 9(3):421-430. PubMed ID: 29351721 [TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase: A new player in autoimmunity. Strzepa A; Pritchard KA; Dittel BN Cell Immunol; 2017 Jul; 317():1-8. PubMed ID: 28511921 [TBL] [Abstract][Full Text] [Related]
11. The other myeloperoxidase: Emerging functions. Vanhamme L; Zouaoui Boudjeltia K; Van Antwerpen P; Delporte C Arch Biochem Biophys; 2018 Jul; 649():1-14. PubMed ID: 29614255 [TBL] [Abstract][Full Text] [Related]
12. The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress. Lin W; Chen H; Chen X; Guo C Antioxidants (Basel); 2024 Jan; 13(1):. PubMed ID: 38275657 [TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase: Mechanisms, reactions and inhibition as a therapeutic strategy in inflammatory diseases. Davies MJ Pharmacol Ther; 2021 Feb; 218():107685. PubMed ID: 32961264 [TBL] [Abstract][Full Text] [Related]
15. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Eiserich JP; Hristova M; Cross CE; Jones AD; Freeman BA; Halliwell B; van der Vliet A Nature; 1998 Jan; 391(6665):393-7. PubMed ID: 9450756 [TBL] [Abstract][Full Text] [Related]
17. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation. Anderson MM; Hazen SL; Hsu FF; Heinecke JW J Clin Invest; 1997 Feb; 99(3):424-32. PubMed ID: 9022075 [TBL] [Abstract][Full Text] [Related]
18. Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid and hypothiocyanous acid with human coronary artery endothelial cells. Lloyd MM; Grima MA; Rayner BS; Hadfield KA; Davies MJ; Hawkins CL Free Radic Biol Med; 2013 Dec; 65():1352-1362. PubMed ID: 24120969 [TBL] [Abstract][Full Text] [Related]
19. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Gaut JP; Yeh GC; Tran HD; Byun J; Henderson JP; Richter GM; Brennan ML; Lusis AJ; Belaaouaj A; Hotchkiss RS; Heinecke JW Proc Natl Acad Sci U S A; 2001 Oct; 98(21):11961-6. PubMed ID: 11593004 [TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase: the yin and yang in tumour progression. Mika D; Guruvayoorappan C J Exp Ther Oncol; 2011; 9(2):93-100. PubMed ID: 21699016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]